ESC Advisors wants to meet with companies looking to raise capital at BioPharm America. “Working with smaller companies takes us beyond traditional investment banking because it gives us an opportunity to roll up our sleeves as an advisor to the company and work hands-on with the management team,” says Evonne Sepsis, Founder, ESC Advisors. Read more »
Ahead of BioPharm America 2010 in Boston, Nycomed’s lead dealmaker, Kerstin Valinder, offers an in-depth discussion of partnering that jumps to the top of our ‘Summer Reading’ list. In this exclusive interview with partneringNEWS she traces the company’s spectacular growth to EUR 3 billion in sales, outlines Nycomed’s targets for further growth, and shares fresh views on how the ‘professionalization’ of partnering changes business development. Read more »
“In the life science industry, there are purely scientific meetings, and then there are pure dealmaking events, yet intelligent business development requires elements of both,” said Ed Saltzman. Read more »
A featured speaker and panelist at conferences produced by EBD Group, Michael Yeomans consistently offers BIO-Europe Spring participants insights into industry trends and inspires discussions on future directions for dealmaking.
Dr Yeomans joined Bayer Schering Pharma in April 2007 as Senior Vice President, Head of Global Business Development & Licensing, based in Berlin. His arrival stirred Read more »
Spanish biotechnology is growing nearly 15 percent annually. Montserrat Vendrell says that is three times higher than German growth and five times higher than USA. Although the information is downplayed by countries, Spain is the country that has experienced the best biotechnological results in the last seven years. Read more »
In an exclusive interview with partneringNEWS, Dr Masana sets out the strategic directions for Esteve through to 2015 and describes the qualities the company seeks in new programs. Read more »
One year after a market meltdown that sent other banks running for coverage under the TARP fund Rodman & Renshaw is expanding business and posting record revenue. Read more »
As diagnostics are rapidly becoming key tools in managing the entire life cycle of a drug pharmaceutical companies have big decisions to make about how they incorporate diagnostics into their business models. Read more »
Newsletter